Related by context. All words. (Click for frequent words.) 72 Doxil ® 71 ABVD 71 daunorubicin 70 concurrent chemoradiation 70 pegylated interferon alfa 2b 70 fluorouracil 69 CHOP chemotherapy 69 mitoxantrone 69 5-FU/LV 69 chemoradiotherapy 69 doxorubicin cyclophosphamide 69 carboplatin paclitaxel 69 pegylated liposomal doxorubicin 69 Peg IFN 69 Fludara 68 mycophenolate mofetil 68 interferon ribavirin 68 adriamycin 68 preoperative chemotherapy 68 piperacillin tazobactam 68 clodronate 68 doxorubicin docetaxel 68 chemoradiation therapy 68 docetaxel chemotherapy 68 postoperative chemotherapy 67 FOLFIRI 67 standard chemotherapy regimen 67 chemotherapy docetaxel 67 Irinotecan 67 dose cytarabine 67 mRCC 67 paclitaxel carboplatin 67 estramustine 67 ritonavir boosted lopinavir 67 efavirenz EFV 67 chemo radiotherapy 67 neoadjuvant chemotherapy 67 decitabine 67 taxotere 67 sorafenib Nexavar 67 octreotide LAR 67 5FU 67 mg/m2 dose 67 XELOX 67 liposomal doxorubicin 66 baseline LDH 66 interferon alfa 66 Paraplatin ® 66 Folfox 66 etoposide 66 comparator PI r 66 fluorouracil leucovorin 66 topotecan 66 cisplatin chemotherapy 66 Capecitabine 66 Mitomycin C 66 placebo dexamethasone 66 mapatumumab 66 Pegylated Interferon 66 FOLFIRINOX 66 FOLFOX4 66 flutamide 66 Gemcitabine 66 Platinol ® 66 atazanavir ritonavir 66 ritonavir boosted 66 FOLPI 66 locoregional disease 66 Flu Cy 66 chlorambucil 66 Nilotinib 66 vinorelbine 66 Neulasta ® 66 mg kg dose 66 gemcitabine chemotherapy 66 infusional 5-FU/LV 66 neoadjuvant therapy 66 mg QD 65 Neoadjuvant 65 FOLFOX 65 Pemetrexed 65 #mg/m# [002] 65 Taxotere ® 65 comparator arm 65 plus prednisone 65 paricalcitol 65 median PFS 65 CCyR 65 adjuvant cisplatin 65 MGd 65 pCR 65 ara C 65 DOXIL 65 neoadjuvant 65 adjuvant radiotherapy 65 LPV r 65 azacitidine 65 cytoreduction 65 androgen suppression 65 peginterferon alfa 2a 65 azathioprine 65 IFN alfa 65 cisplatin gemcitabine 65 pegylated interferon alpha 65 paclitaxel Taxol 65 lopinavir r 65 relapsed MM 65 gemcitabine carboplatin 65 trials RCTs 64 dose cyclophosphamide 64 relapsed ovarian cancer 64 oral clodronate 64 bendamustine 64 Camptosar ® 64 HBeAg seroconversion 64 viral kinetics 64 FOLFIRI alone 64 cinacalcet 64 refractory prostate cancer 64 darunavir r 64 APTIVUS 64 PEG IFN 64 levosimendan 64 Platinol ® cisplatin 64 #mg QD [001] 64 bleomycin 64 follicular lymphoma FL 64 LHRH agonist 64 biochemical relapse 64 prednisone prednisolone 64 nonmetastatic 64 Free Survival PFS 64 receiving VICTRELIS 64 abacavir lamivudine 64 docetaxel 64 5 FU leucovorin 64 Taxol paclitaxel 64 hematologic toxicity 64 sunitinib 64 alfa 2a 64 lenalidomide dexamethasone 64 docetaxel Taxotere 64 p = #.# [003] 64 antiandrogen 64 sipuleucel T 64 rFSH 64 metastatic renal cell carcinoma 64 adalimumab Humira 64 chemoradiation 64 Fulvestrant 64 amoxicillin clavulanate 64 antihypertensive therapy 64 ACTEMRA TM 64 Xelox 64 dose cohort 64 dose dexamethasone 64 rituximab Rituxan 64 CsA 64 FOLFOX6 64 gefitinib Iressa 64 DAPT 64 FUSILEV enhances 64 lymphadenectomy 63 p = NS 63 q8h 63 dexamethasone Decadron 63 alpha 2a 63 cabazitaxel 63 bicalutamide 63 Amrubicin 63 paclitaxel cisplatin 63 PegIFN RBV 63 pertuzumab 63 evaluating tivozanib 63 Hycamtin ® 63 Natalizumab 63 oblimersen 63 debulking surgery 63 TORISEL 63 DMARD therapy 63 idarubicin 63 EBRT 63 Oxaliplatin 63 surgical debulking 63 Median PFS 63 Sorafenib 63 APTIVUS r 63 CLL SLL 63 vandetanib 63 adalimumab 63 IFN α 63 Etoposide 63 GnRH agonist 63 epirubicin 63 Platinol 63 bacillus Calmette Guerin 63 Erlotinib 63 Aptivus ® 63 progression TTP 63 BARACLUDE ® 63 temsirolimus 63 ELOXATIN 63 Lenalidomide 63 goserelin 63 PSA nadir 63 locoregional 63 Alkeran 63 Fludarabine 63 neurologic progression 63 severe neutropenia 63 ixabepilone 63 tigecycline 63 Adjuvant chemotherapy 63 dalteparin 63 sustained virological response 63 dasatinib 63 YERVOY 63 fallopian tube carcinoma 63 complete cytogenetic response 63 tenofovir emtricitabine 63 #mg BID [001] 63 oral deforolimus 63 refractory AML 63 adjuvant tamoxifen 63 methotrexate monotherapy 63 CANCIDAS 63 recurrent glioblastoma multiforme 63 plus dexamethasone 63 pegfilgrastim 63 titrated glipizide 63 dacarbazine 63 Follicular Lymphoma 63 nab paclitaxel 63 PSMA ADC 63 AVONEX ® 63 Epirubicin 63 peginterferon alfa 2a #KD 63 TMC# r 63 Trastuzumab 63 Jevtana 63 bevacizumab Avastin 63 docetaxel prednisone 63 certolizumab 63 Taxotere chemotherapy 63 APTIVUS R 63 STRIDE PD 63 salmeterol fluticasone propionate 63 pegylated interferon alfa 63 sunitinib malate 63 KRAS mutant tumors 63 sulfasalazine 63 iniparib 63 androgen deprivation 63 IFN beta 63 sunitinib Sutent 62 CIMZIA TM 62 Metastatic Prostate Cancer 62 virological failure 62 tipranavir r 62 Bezielle 62 ritonavir boosted atazanavir 62 external beam radiotherapy 62 Caelyx 62 gemcitabine Gemzar 62 Mitoxantrone 62 Cloretazine 62 Taxotere docetaxel 62 oral diclofenac 62 fluoropyrimidine 62 fludarabine cyclophosphamide 62 cisplatin 62 Neupogen ® 62 Ceplene/IL-2 62 isoproterenol 62 plus 5-FU/LV 62 aflibercept 62 tamsulosin 62 Peginterferon 62 oxycodone CR 62 #mg/day [001] 62 zoledronate 62 Carboplatin 62 Monotherapy 62 nadolol 62 platinum refractory 62 VIDAZA 62 Gemzar ® 62 AZT zidovudine Retrovir 62 virologic failure 62 achieved CCyR 62 chemotherapeutic regimen 62 Toxicities 62 ABC/3TC 62 recurrent GBM 62 CR nPR 62 Retreatment 62 5 Fluorouracil 62 #Gy 62 lapatinib Tykerb 62 tipranavir 62 AEGR 62 recurrent metastatic 62 LHRH agonists 62 Velcade bortezomib 62 carboplatin 62 oral rivaroxaban 62 unfractionated heparin UFH 62 Cisplatin 62 cytotoxic chemotherapy 62 VIRAMUNE 62 5-fluorouracil/leucovorin 62 μmol L 62 CA4P 62 oral allopurinol 62 epirubicin cyclophosphamide 62 docetaxel Taxotere ® 62 stage IIIB 62 mCi kg 62 #mg/m# [001] 62 F FDG PET 62 gemcitabine cisplatin 62 Hazard Ratio 62 alkylating agent 62 4mg/kg 62 tirofiban 62 mitomycin 62 TMP SMX 62 curative resection 62 ULORIC 62 VELCADE melphalan 62 boosted protease inhibitor 62 ibandronate 62 antiangiogenic therapy 62 TPV r 62 pyrazinamide 62 mcg QD 62 paclitaxel poliglumex 62 TTF Therapy 62 cytoreductive surgery 62 mcg BID 62 bevacizumab Avastin ® 62 Femara letrozole 62 stavudine d4T 62 BCIRG 62 radiotherapy RT 62 biochemical recurrence 62 CAELYX 62 metastatic malignant 62 intratumoral 62 lumbar spine BMD 62 eplerenone 62 TAXOTERE R 62 fludarabine 62 invasive candidiasis 62 Nexavar sorafenib 61 endometrial carcinoma 61 mg qd 61 intermittent dosing 61 trastuzumab Herceptin ® 61 idraparinux 61 dose clopidogrel 61 virologic response 61 relapsed CLL 61 fosamprenavir 61 mitoxantrone plus 61 erlotinib Tarceva ® 61 Pegylated Liposomal Doxorubicin 61 mg m² 61 5 fluorouracil 61 trimethoprim sulfamethoxazole 61 chemotherapeutic regimens 61 Docetaxel 61 biliary tract cancer 61 neoadjuvant treatment 61 Pegasys plus Copegus 61 adjuvant radiation 61 GnRH agonists 61 sorafenib Nexavar ® 61 HIV RNA 61 DFMO 61 TACE 61 deferoxamine 61 irinotecan chemotherapy 61 lopinavir r arm 61 q#h 61 salmeterol fluticasone 61 Decitabine 61 insulin detemir 61 ribavirin RBV 61 caspofungin 61 Revlimid lenalidomide 61 adefovir 61 cyclophosphamide methotrexate 61 Leucovorin 61 Combination therapy 61 androgen ablation 61 Taxotere R 61 degarelix 61 metastatic GIST 61 ancrod 61 cyclophosphamide doxorubicin vincristine 61 vorinostat 61 Sanofi Aventis Taxotere 61 mutated KRAS 61 peginterferon 61 rapid virologic response 61 RGT arm 61 squamous histology 61 Fluorouracil 61 mcg albinterferon alfa 2b 61 steroid dexamethasone 61 low dose cytarabine 61 paclitaxel eluting stents 61 demonstrated antitumor activity 61 inhibitor RG# 61 sorafenib tablets 61 Newly Diagnosed Multiple Myeloma 61 tanespimycin 61 endocrine therapies 61 FASLODEX 61 antimetabolite 61 Bevacizumab 61 antitumor effect 61 relapsing multiple sclerosis 61 ethambutol 61 rFVIIa 61 hypofractionated 61 pegIFN 61 imatinib Gleevec 61 PegIFN 61 Gleevec resistant 61 peg interferon 61 saline placebo 61 NATRECOR R 61 urothelial carcinoma 61 Helicobacter pylori eradication 61 peginterferon alfa 2b 61 EURIDIS 61 Bosentan 61 trabectedin 61 pomalidomide 61 lumiliximab 61 PSADT 61 Torisel 61 mg BID 61 recurrent VTE 61 serum urate levels 61 intravenous cyclophosphamide 61 fondaparinux 61 CYPHER Stent 61 capecitabine Xeloda 61 uric acid lowering 61 teriflunomide 61 irbesartan 61 BRIM2 61 ER CHOP 61 Dasatinib 61 resectable 61 thalidomide dexamethasone 61 CIMZIA TM certolizumab pegol 61 Vidaza azacitidine 61 sustained virologic response 61 Adefovir 61 adjuvant trastuzumab 61 perioperatively 61 imatinib therapy 61 KRAS status 61 dose regimens 61 BENICAR HCT 61 fluvastatin 61 posaconazole 61 antithymocyte globulin 61 canakinumab 61 dose atorvastatin 61 imatinib 61 Copegus ribavirin 61 NOXAFIL 61 Bortezomib 61 mesalazine 61 grade cervical intraepithelial 61 Noxafil 61 metastatic RCC 61 platelet inhibitor 61 dosage regimens 61 Pioglitazone 61 cytarabine daunorubicin 61 temozolomide 61 ZYVOX 61 febrile neutropenia 61 amphotericin B 61 octreotide 61 epirubicin cisplatin 61 CIMZIA ™ 61 cetuximab 61 LEXIVA r 61 locoregional recurrence 61 low dose Iluvien 61 assessing T DM1 61 sorafenib 61 adefovir dipivoxil 61 Kaplan Meier analysis 61 DMARD 61 resected pancreatic cancer 60 LANTUS R 60 ALA PDT 60 therapeutic regimens 60 castrate resistant 60 Exemestane 60 neutrophil counts 60 microwave hyperthermia 60 darunavir ritonavir 60 virological response 60 cytotoxic therapy 60 ceftazidime 60 Pertuzumab 60 6 mercaptopurine 60 imetelstat 60 liposomal amphotericin B 60 8mg/kg 60 ascending dose 60 underwent surgical resection 60 Interferon Alfa 60 adenoma recurrence 60 dose interleukin 60 Relapsing Remitting Multiple Sclerosis 60 cilengitide 60 intravesical therapy 60 Ixempra 60 clinically localized prostate 60 fluticasone salmeterol 60 indinavir 60 Temsirolimus 60 colorectal cancer liver metastases 60 SCCHN 60 forodesine 60 metastatic kidney 60 Adjuvant Therapy 60 β blockers 60 superficial bladder cancer 60 INCB# [003] 60 mycophenolate 60 telaprevir dosed 60 achieved ACR# 60 noninferior 60 atorvastatin #mg 60 colorectal liver metastases 60 paclitaxel Taxol R 60 ATACAND 60 binary restenosis 60 intravesical 60 mitomycin C 60 paclitaxel chemotherapy 60 Hycamtin 60 metastatic malignant melanoma 60 palifermin 60 cisplatin vinorelbine 60 oxaliplatin Eloxatin 60 5 fluorouracil leucovorin 60 nicardipine 60 care regimens CCR 60 hemorrhagic complications 60 Cyclophosphamide 60 corifollitropin alfa 60 TroVax ® 60 anastrazole 60 cytoreductive nephrectomy 60 peginterferon alpha 2a 60 #mg/day [002] 60 ziprasidone 60 micafungin 60 Faslodex 60 ZACTIMA 60 serum creatinine levels 60 Betaferon R 60 adecatumumab 60 Peginterferon alfa 2b 60 stage IIIb IV 60 Vandetanib 60 sulfadoxine pyrimethamine 60 Fludara ® 60 galiximab 60 Sprycel dasatinib 60 divalproex sodium 60 low dose dexamethasone 60 protease inhibitors PIs 60 abiraterone acetate 60 nondiabetic patients 60 Cytoxan 60 Filgrastim 60 gemcitabine 60 zonisamide SR 60 rizatriptan 60 MabCampath 60 beta blocker therapy 60 glatiramer acetate 60 mcg kg 60 tipranavir ritonavir 60 Gefitinib 60 leucovorin 60 Gliadel Wafer 60 peg IFN 60 % CI #.#-#.# [003] 60 Elitek 60 squamous cell carcinoma SCC 60 lamivudine monotherapy 60 tacrolimus ointment 60 Chemoradiation 60 ORENCIA ® 60 EndoTAGTM 1 60 P = .# 60 Aflibercept 60 PASI scores 60 CYP#D# inhibitor 60 HBeAg negative patients 60 bolus dose 60 statin monotherapy 60 interferon beta 1a 60 bosentan 60 dasatinib Sprycel 60 oral Hycamtin 60 iodixanol 60 Virologic 60 protease inhibitor PI 60 GOUT 60 Anthracycline 60 intravenous dosing 60 postoperative mortality 60 antimicrobial prophylaxis 60 liver metastasis 60 Adjuvant Treatment 60 invasive ductal 60 Azacitidine 60 Ibritumomab Tiuxetan 60 nitazoxanide 60 GRASPA ® 60 ovarian carcinoma 60 nilotinib 60 chemotherapy cisplatin 60 INTELENCE 60 endometrial hyperplasia 60 azacytidine 60 elotuzumab 60 CTAP# Capsules 60 Phase Ib clinical 60 monotherapy 60 sitaxsentan 60 corticosteroid therapy 60 gemcitabine Gemzar ® 60 esomeprazole 60 Gleevec imatinib 60 otamixaban 60 KRAS mutations occur 60 Herceptin trastuzumab 60 SPRYCEL ® 60 metastatic bladder 60 Panitumumab 60 prostate cancer CaP 60 pancreatic adenocarcinoma 60 olmesartan 60 Tumor Response 60 virological suppression 60 axitinib 60 Subgroup analysis 60 Telbivudine 60 metastatic castration resistant 60 PEG interferon 60 BAY #-# 60 Interferon beta 60 PEGINTRON TM 60 plus gemcitabine 60 sevelamer 60 alefacept 60 seminoma 60 #mg BID [003] 60 Eli Lilly Gemzar 60 CBLC# 60 VAPRISOL 60 Gleevec imatinib mesylate 60 pegylated liposomal doxorubicin PLD 60 adjuvant therapies 60 Proxinium TM 60 ALVESCO 59 -#.# log# 59 abacavir Ziagen 59 postoperative radiotherapy 59 androgen blockade 59 bezafibrate 59 HbA 1c levels 59 leukemia AML 59 biologic DMARD 59 clopidogrel Plavix 59 prospectively stratified 59 Darusentan 59 PEGPH# 59 cetuximab Erbitux ® 59 cytotoxic therapies 59 INFERGEN 59 Roche Xeloda 59 tesmilifene 59 cediranib 59 cilostazol 59 randomized multicenter Phase III 59 TAXOTERE ® 59 adjunctive placebo 59 mg clopidogrel 59 Prolongs Survival 59 fulvestrant 59 dose melphalan 59 recurrent NSCLC 59 tamoxifen Nolvadex ® 59 fluconazole 59 tocilizumab 59 completely resected 59 Gleevec Glivec 59 NSABP B 59 chlorthalidone 59 pT3 59 Cetuximab 59 anemia hemoglobin 59 Pharmacokinetics PK 59 tiotropium 59 CIN3 59 cyclophosphamide chemotherapy 59 dutasteride 59 receptor tyrosine kinase inhibitor 59 Tipranavir 59 localized renal 59 Tarceva TM 59 patients evaluable 59 plus ribavirin 59 mg RDEA# 59 mitoxantrone chemotherapy 59 imipenem 59 EGFR tyrosine kinase inhibitors 59 invasive aspergillosis 59 Metastatic Colorectal Cancer 59 Teriflunomide 59 variceal hemorrhage 59 pegylated interferon ribavirin 59 icatibant 59 posttreatment 59 colorectal adenoma 59 corticosteroid dexamethasone 59 μg kg 59 Vectibix monotherapy 59 visilizumab 59 REYATAZ R 59 hormone refractory metastatic prostate 59 TEMODAL 59 Taxotere 59 voriconazole 59 argatroban 59 Moxifloxacin 59 mg TID 59 NovoTTF 59 #mg QD [002] 59 #mg/kg [002] 59 Platelet counts 59 FluCAM 59 RECIST Response Evaluation Criteria 59 Betaferon ® 59 tolvaptan 59 concomitant medications 59 Dose escalation 59 abatacept 59 standard chemotherapy regimens 59 intravenous vancomycin 59 Paraplatin ® carboplatin 59 gastric adenocarcinoma 59 amprenavir 59 CPOP R 59 serum urate 59 gliclazide 59 refractory colorectal cancer 59 grade gliomas 59 NMIBC 59 afatinib 59 mg hydrochlorothiazide 59 pamidronate 59 hematologic parameters 59 recurrent malignant glioma 59 gemifloxacin 59 oxaliplatin 59 chemotherapeutic drug 59 rindopepimut 59 allogeneic HSCT 59 androgen independent 59 eptifibatide 59 cyclophosphamide 59 splenectomized patients 59 temozolomide TMZ 59 relapsing remitting MS RRMS 59 advanced hepatocellular carcinoma 59 paliperidone ER 59 mesilate 59 taxane chemotherapy 59 AGILECT R 59 Patients Receiving 59 NEVO ™ 59 active comparator 59 tolterodine ER 59 rosuvastatin #mg 59 Pred Forte 59 stavudine 59 cefuroxime 59 capecitabine 59 adjuvant chemotherapy 59 FROVA 59 anastrozole 59 GW# [003] 59 candidemia 59 chemotherapy regimens 59 Thal Dex 59 seliciclib 59 Elotuzumab 59 trastuzumab DM1 59 tiuxetan 59 Degarelix 59 linezolid 59 SCIg 59 insulin glulisine 59 COMBIVIR 59 doxazosin 59 nonmetastatic prostate cancer 59 daily subcutaneous injections 59 rituximab 59 aspirin clopidogrel 59 hematopoietic cancers 59 Bevacizumab Avastin 59 NATRECOR ® 59 eribulin mesylate 59 genotypic resistance 59 TNF antagonist 59 pimecrolimus cream 59 budesonide foam 59 cardiac toxicity 59 desvenlafaxine succinate 59 Allogeneic 59 3TC lamivudine Epivir 59 advanced adenomas 59 NRTI 59 conventional DMARDs 59 Pegintron 59 cis retinoic acid 59 pemetrexed 59 immunosuppressive regimen 59 operable breast cancer 59 radiochemotherapy 59 myeloablative 59 Kaplan Meier 59 docetaxel pretreated 59 ezetimibe simvastatin 59 oral vancomycin 59 heavily pretreated patients 59 interferon alfa 2a 59 Carvedilol 59 Ribavirin 59 relapsed refractory multiple myeloma 59 TELCYTA 59 postintervention 59 PREZISTA r 59 TDF FTC 59 etanercept Enbrel 59 intravenous bisphosphonates 59 HCV RESPOND 2 59 cidofovir 59 lanthanum carbonate 59 Solid Tumors 59 Response Evaluation Criteria 59 median survivals 59 adjuvant colon cancer 59 hepatic metastases 59 leuprorelin 59 mg BID dose 59 gadobutrol 59 clomipramine 59 denileukin diftitox 59 NRTIs 59 CK # plasma concentrations 59 FEMALES SHOULD BE ADVISED 59 PEG Intron 59 transaminase elevations 59 chemotherapy FOLFOX 59 Patients Treated 59 pegylated IFN 59 urate lowering therapy 59 CR CRu 59 neutropenic 59 mycophenolic acid 59 valacyclovir 59 cytogenetic abnormalities 59 low dose ritonavir 59 candesartan cilexetil 59 olaparib 59 pegylated interferon alfa 2a 59 interferon alfa 2b 59 Drug eluting stent 59 Camptosar 59 mesalamine granules 59 administered subcutaneously 59 prostate cancer HRPC 59 Darunavir 59 antiretroviral naïve 59 TAXUS Liberte Stent 59 acute gout flares 59 reinfarction 59 thromboembolic events 59 ribavirin therapy 59 immunomodulatory therapy 59 hydroxymethyl coenzyme 59 tenecteplase 59 phase IIb clinical 59 autologous SCT 59 REVLIMID R 59 basiliximab 59 Bivalirudin 59 fosbretabulin 59 suppressive therapy 59 HIPEC 59 serum phosphorus 59 beta 1a 59 FIRMAGON 59 ELACYT 59 tumor histology 59 response CCyR 59 remission induction 59 lenalidomide Revlimid 59 dose cohorts 59 plasma uric acid 59 Crestor rosuvastatin 59 Omacetaxine 59 prostate carcinoma 59 dose escalation 59 Pegasys peginterferon alfa 2a 59 Telintra 59 infusional 59 HBeAg negative 59 Celecoxib 59 Rituximab 59 venous thromboembolic events 59 undetectable viral 59 allogeneic SCT 59 haematologic 59 dose regimen 59 postoperative morbidity 59 injected subcutaneously 59 unresectable stage 58 antibiotic regimens 58 Dacogen decitabine 58 alfa 2b 58 conventional angiography 58 MYCAMINE 58 thalidomide Thalomid 58 Squamous 58 undetectable HBV DNA 58 rosuvastatin Crestor 58 melphalan prednisone 58 Severe Sepsis 58 Interferon beta 1b 58 diuretic chlorthalidone 58 serum phosphate 58 Relapsing Multiple Sclerosis 58 atazanavir 58 crizotinib PF # 58 nephrectomy 58 TYGACIL 58 trans retinoic acid 58 Laquinimod 58 plus methotrexate 58 CLARITY study 58 MAGE A3 ASCI 58 VNP#M 58 ximelagatran 58 Roche Herceptin 58 Castration Resistant Prostate Cancer 58 experienced virologic failure 58 oral methylnaltrexone 58 heavily pretreated 58 trastuzumab Herceptin R 58 antiplatelet therapy 58 Plus Ribavirin 58 tobramycin inhalation solution 58 ug kg 58 cystectomy 58 Panzem R NCD 58 entecavir 58 polyp recurrence 58 Hydroxyurea 58 vicriviroc 58 Antitumor Activity 58 Xeloda ® 58 clinicopathological features 58 ablative therapy 58 #mg ATC 58 HER2 positive metastatic breast 58 DAS# scores 58 glulisine 58 receiving highly emetogenic 58 mycophenolate mofetil MMF